VITAMIN C (L-ASCORBIC ACID)

The Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD), in collaboration with the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), is conducting a market survey to identify qualified small businesses, including various disadvantaged groups capable of supplying C13 labeled vitamin C. This procurement aims to support metabolic research protocols requiring specific isotopes that comply with NIH’s standards for clinical use. The requirements include providing a Certificate of Analysis detailing chemical purity, isotopic enrichment, absence of animal-derived materials, and meeting USP standards, among other specifications. The product, 0.75g of C13 labeled vitamin C, is scheduled for delivery in March 2025. Interested businesses must submit a capability statement demonstrating their qualifications by December 4, 2024. Specific details, such as business size, type, and documentation confirming reseller authorization, are mandated. The notice underscores the government's rights regarding submission evaluations and clarifies that responding does not obligate the government to award a contract. This announcement targets small businesses and aims to ensure compliance with Federal Acquisition Regulations in preparing for potential procurement.